A Randomized, Open-label Study of the Effect of Intermittent Xeloda Versus iv Fluorouracil/Leucovorin, Both in Combination With Eloxatin, on Tumor Progression in Patients With Metastatic Colorectal Cancer Who Received Prior CPT-11 and 5-fluorouracil/Leucovorin
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Time to tumor progression
Event driven
No
Clinical Trials
Study Director
Hoffmann-La Roche
United States: Food and Drug Administration
NO16967
NCT00069108
May 2003
January 2008
Name | Location |
---|---|
Bettendorf, Iowa 52722 | |
Great Falls, Montana 59405 | |
Fountain Valley, California 92708 | |
Miami, Florida 33176 | |
Columbia, Missouri 65203 | |
Albany, New York 12208 | |
Philadelphia, Pennsylvania 19104 | |
Nashville, Tennessee 37203-1632 | |
Austin, Texas 78705 | |
Seattle, Washington 98195 | |
Omaha, Nebraska 68114 | |
Hackensack, New Jersey 07601 | |
Albuquerque, New Mexico 87131-5636 | |
Denver, Colorado | |
Milwaukee, Wisconsin | |
Indianapolis, Indiana | |
Washington, District of Columbia | |
Salt Lake City, Utah 84112 |